16:50:16 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


2023-08-24 Kvartalsrapport 2023-Q2
2023-04-28 Årsstämma 2023
2023-03-31 Bokslutskommuniké 2022
2022-08-24 Kvartalsrapport 2022-Q2
2022-06-10 Ordinarie utdelning ABT 0.00 NOK
2022-06-09 Årsstämma 2022
2022-04-29 Bokslutskommuniké 2021
2021-08-25 Kvartalsrapport 2021-Q2
2021-06-10 Ordinarie utdelning ABT 0.00 NOK
2021-06-09 Årsstämma 2021
2021-04-30 Bokslutskommuniké 2020
2020-09-11 Extra Bolagsstämma 2020
2020-08-26 Kvartalsrapport 2020-Q2
2020-06-11 Ordinarie utdelning ABT 0.00 NOK
2020-06-10 Årsstämma 2020
2020-04-15 Bokslutskommuniké 2019
2019-08-28 Kvartalsrapport 2019-Q2
2019-06-06 Ordinarie utdelning ABT 0.00 NOK
2019-06-05 Årsstämma 2019
2019-04-24 Bokslutskommuniké 2018
2019-01-07 Extra Bolagsstämma 2019
2018-08-22 Kvartalsrapport 2018-Q2
2018-05-30 Årsstämma 2018
2018-02-21 Bokslutskommuniké 2017
2017-08-16 Kvartalsrapport 2017-Q2
2017-06-08 Ordinarie utdelning ABT 1.00 NOK
2017-06-07 Årsstämma 2017
2017-02-15 Bokslutskommuniké 2016
2016-11-18 Bonusutdelning ABT 1
2016-11-17 Kvartalsrapport 2016-Q3
2016-11-17 Extra Bolagsstämma 2016
2016-08-17 Kvartalsrapport 2016-Q2
2016-06-09 Ordinarie utdelning ABT 1.50 NOK
2016-06-08 Årsstämma 2016
2016-05-11 Kvartalsrapport 2016-Q1
2016-02-10 Bokslutskommuniké 2015
2015-11-18 Kvartalsrapport 2015-Q3
2015-08-19 Kvartalsrapport 2015-Q2
2015-06-04 Ordinarie utdelning ABT 1.00 NOK
2015-06-03 Årsstämma 2015
2015-05-13 Kvartalsrapport 2015-Q1
2015-02-11 Bokslutskommuniké 2014
2014-11-26 Kvartalsrapport 2014-Q3
2014-08-20 Kvartalsrapport 2014-Q2
2014-06-11 Årsstämma 2014
2014-05-21 Kvartalsrapport 2014-Q1
2014-02-12 Bokslutskommuniké 2013
2013-11-27 Kvartalsrapport 2013-Q3
2013-08-21 Kvartalsrapport 2013-Q2
2013-06-13 Kapitalmarknadsdag 2013
2013-06-12 Ordinarie utdelning
2013-06-11 Årsstämma 2013
2013-05-22 Kvartalsrapport 2013-Q1
2013-02-13 Bokslutskommuniké 2012
2012-11-27 Kvartalsrapport 2012-Q3
2012-08-28 Kvartalsrapport 2012-Q2
2012-06-14 Årsstämma 2012
2012-05-23 Kvartalsrapport 2012-Q1
2012-02-17 Bokslutskommuniké 2011
2011-11-30 Kvartalsrapport 2011-Q3
2011-08-29 Kvartalsrapport 2011-Q2
2011-06-17 Ordinarie utdelning
2011-06-16 Årsstämma 2011
2011-05-30 Kvartalsrapport 2011-Q1
2011-02-18 Bokslutskommuniké 2010


ListaOAX Equities
Aqua Bio Technology är ett norskt bolag verksamma inom kosmetikabranschen. Bolaget utvecklar, tillverkar och kommersialiserar ingredienser som används inom ett flertal kosmetiska produkter världen över. Störst verksamhet återfinns inom lösningar för hudvårdsprodukter. Merparten av bolagets produkter säljs på en global marknad via diverse distributörer. Bolaget grundades 2004 och har sitt huvudkontor i Lysaker.
2022-08-24 08:01:01
24.8.2022 08:01:00 CEST | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state

* Signed term sheet for the purchase of Cosmed Beauty AS and Ultrabody AB,
which secures and expands the distribution of the company's brands as well as
significantly increases margins.
* The skincare industry is fragmented with a vast number of e.g. distributors.
ABT sees beneficial consolidation opportunities in this market and shows, via
the purchase of Cosmed Beauty AS and Ultrabody AB, a step towards
consolidation which will be beneficial for ABTs investors.
* Entered into an exclusive 3-year distribution agreement end of June with
Mentellow Beauty Brands AS for sale of Seiðr og Seiðr clinique in Norway,
Sweden, Denmark and Finland. Expected launch is early in 2H-2022.
* Entered into a non-exclusive retailer agreement with Shop By Sorthe AS end of
April for Seiðr and Seiðr clinique in the Norwegian market.
* LifeMD launched products containing Aquabeautine XL in all US states.
* Signed an agreement for the exclusive distribution of Moana Skincare, Seiðr
and Seiðr clinique with Egy-Kuwait Trading Company for the Kuwaiti market.
* Hydrafacial launched products that contain Aquabeautine XL in the UK.
* Restorsea launched its own products based on Aquabeautine XL in the Shilla
IPARK Duty Free Shop in South Korea which is the world's largest duty-free
* Restorsea extended its supply agreement for Aquabeautine XL for 5 new years.

The company's revenues in the first half of 2022 were NOK 0.5 million versus NOK
0.7 million in the same period last year. About 88% of the revenue was from the
sale of skincare products. The remaining revenue comes from the collaboration
with ABT's US partner Restorsea. Cost of goods amounted to NOK 3.3 million in
the first half of the year, compared with NOK 1.0 million in the same period
last year. The company's operating expenses (excluding cost of goods) were NOK
8.1 million in the first half of 2022. In the same period last year, operating
expenses were NOK 8.1 million. EBITDA for the first half of 2022 was NOK -10.9
million, which is weaker compared with the corresponding period last year, when
EBITDA was NOK -8.4 million. ABT's profit after tax was NOK -12.4 million,
compared with NOK -9.4 million in the first half of 2021. The equity ratio at
the end of the first half of 2022 was 36% versus 50.5% after the first half of


This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.


* Håvard Lindstrøm, 004794132288, hl@aquabiotech.no


Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.


Download announcement as PDF.pdf -

Halvarsrapport 24 august 2022 final.pdf -